NEW DELHI, Dec 1 (Reuters) - Serum Institute of India (SII) has pledged to supply about 40 million doses of the AstraZeneca (AZN.L), opens new tab COVID-19 shot to the global vaccine-distribution ...
In trading on Friday, shares of Sprott Inc (Symbol: SII) crossed above their 200 day moving average of $43.15, changing hands as high as $44.86 per share. Sprott Inc shares are currently trading up ...
Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla, on Thursday said the vaccine manufacturer stopped the production of Covishield vaccine starting December 2021, and of the ...
Sprott Inc. Annual stock financials by MarketWatch. View the latest SII financial statements, income statements and financial ratios.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results